InnoCare Pharma Goes Back to Funding Trough With STAR Market Listing
The Hong Kong-traded company will become the latest from the cash-challenged pharma sector to make a second listing on the A-share market Key Takeaways: InnoCare Pharma’s A-share IPO will make…
RELATED ARTICLES
-
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
9969.HK -
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
